To divide or not to divide: revisiting liver regeneration
© Miyaoka and Miyajima; licensee BioMed Central Ltd. 2013
Received: 6 June 2013
Accepted: 17 June 2013
Published: 20 June 2013
The liver has a remarkable capacity to regenerate. Even with surgical removal (partial hepatectomy) of 70% of liver mass, the remnant tissue grows to recover the original mass and functions. Liver regeneration after partial hepatectomy has been studied extensively since the 19th century, establishing the long-standing model that hepatocytes, which account for most of the liver weight, proliferate to recover the original mass of the liver. The basis of this model is the fact that almost all hepatocytes undergo S phase, as shown by the incorporation of radioactive nucleotides during liver regeneration. However, DNA replication does not necessarily indicate the execution of cell division, and a possible change in hepatocyte size is not considered in the model. In addition, as 15–30% of hepatocytes in adult liver are binuclear, the difference in nuclear number may affect the mode of cell division during regeneration. Thus, the traditional model seems to be oversimplified. Recently, we developed new techniques to investigate the process of liver regeneration, and revealed interesting features of hepatocytes. In this review, we first provide a historical overview of how the widely accepted model of liver regeneration was established and then discuss some overlooked observations together with our recent findings. Finally, we describe the revised model and perspectives on liver regeneration research.
KeywordsAkt Cdks Cellular hypertrophy Cyclins E2F family Hepatocyte Liver regeneration mTOR Partial hepatectomy Polyploidy
The mention of liver regeneration by Prometheus in Greek mythology indicates that ancient people had noticed the regenerative capacity of the liver. Additionally, descriptions of liver regeneration can be traced back to the 19th century when liver mass restoration with spontaneous healing of the scar was recognized after removal of a small portion of the liver . In the early 20th century, it became possible to remove liver lobes by ligating blood vessels to reduce damage to the remnant liver tissue after surgery. In 1931, Higgins and Anderson carefully formulated the currently used procedure for PHx . Notably, they used the term “liver restoration” instead of “liver regeneration” to distinguish clearly between compensatory hyperplasia and true tissue regeneration . Since then, liver regeneration after PHx in rodents has been studied extensively for more than 80 years. Until the 1950s, liver regeneration was analyzed at mainly the tissue or cellular level by microscopic observations [13–15]. In the 1960s, the advent of electron microscopy enabled the analysis of hepatocyte ultrastructure in liver regeneration [16–19]. Almost at the same time, the epoch-making research tool of radioactive isotopes became available for biological studies. This technology was used to show that almost all hepatocytes incorporate radioactive nucleotides during liver regeneration after 70% PHx [20–25]. This landmark observation led to the establishment of the widely accepted concept that all remnant hepatocytes actively divide to recover the original cell number and liver mass (Figure 1C). This long-standing model postulated that all hepatocytes undergo roughly one or two rounds of cell division after 70% PHx [8, 26, 27].
Since the establishment of gene targeting technology in mice in 1989 [28–30], much effort has focused on identifying the genes required for liver regeneration. Many genes have been reported to be involved in liver regeneration after PHx [e.g., β-catenin, methionine adenosyltransferase 1A (MAT1A), oncostatin M (OSM), nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and c-Met] [31–35]. Most of these studies focused on the proliferation or survival of hepatocytes in accordance with the long-standing model. Although an elegant and simple model, accumulating evidence—including our recent findings—suggest that the traditional model of liver regeneration requires revision. We discuss these observations and the proposed revised model in the following sections.
Not all hepatocytes divide
It is well known that hepatocytes accumulate massive amounts of lipids and glycogen immediately after 70% PHx [49–51]. Therefore, the rapid increase in hepatocyte size is at least partly due to lipid and glycogen accumulation. However, the lipid and glycogen amount decreases to normal levels by the completion of liver regeneration, and no obvious change in hepatocyte ultrastructure is observed in regenerated liver after 70% PHx, with the exception of enlarged nuclei . Although several reports have shown that hepatocytes change the size and/or number of various organelles such as mitochondria, lysosomes, endoplasmic reticulum, and ribosomes [16–19, 52], more studies are necessary to reveal the nature of cellular changes in regeneration. Although the detailed mechanism of hypertrophy requires further study, the Akt-mammalian target of rapamycin (mTOR) signaling axis, which regulates the size of various cell types , seems to be an important pathway for hypertrophy in liver regeneration. Akt is a serine-threonine protein kinase with pleiotropic functions such as regulation of cell growth, proliferation, survival, differentiation, and cytoskeletal changes. mTOR is another serine-threonine protein kinase directly phosphorylated by Akt and plays a central role in the functions of Akt. Akt is activated immediately after 30 and 70% PHx, and forced expression of an active form of Akt in hepatocytes increases their size [ and our unpublished data]. Another potential key player is c-Myc, which is a transcription factor involved in cell growth and cell cycle progression. Overexpression or deletion of c-Myc in hepatocytes increases or decreases their size, respectively [54–56]. Interestingly, both Akt-mTOR and c-Myc pathways play critical roles in the enhancement of protein synthesis, indicating that upregulation of gross protein synthesis is one mechanism underlying the hypertrophy of hepatocytes [54, 57]. However, the upstream molecular mechanisms that sense the loss of liver tissue to activate Akt-mTOR and c-Myc pathways remain undefined (see below).
Because hepatocytes increase their size by 1.5-fold and then proliferate after 70% PHx, the 1.5-fold increase in cell size seems to be the threshold for hepatocytes to switch their response from hypertrophy to proliferation. As discussed above, this 1.5-fold size increase is sufficient to restore a 30% loss in liver mass, and hepatocytes do not proliferate after 30% PHx. Therefore, it would be interesting to determine precisely how much liver mass must be removed to induce proliferation. The molecular trigger for hepatocyte proliferation in liver regeneration is unknown. One possible explanation is that the size of the hepatocyte itself is the sensor to drive its cell division cycle, which is considered a general mechanism for activating cell division . Further studies are required to address this question.
Hepatocytes infrequently enter M phase
Polyploidy is a characteristic feature in mammalian hepatocytes, and about 70% of adult hepatocytes in rodents are tetraploid . In general, polyploid cells can arise from failed cytokinesis, mitotic slippage, cell fusion or endoreplication. Polyploid hepatocytes can be either mononuclear or binuclear. Polyploidization of hepatocytes is initiated in postnatal liver growth by incomplete cytokinesis, that produces binuclear polyploid hepatocytes, endoreplication that produces mononuclear polyploid hepatocytes, or both that produce binuclear polyploid hepatocytes [37, 59, 60]. Insulin signaling has been implicated in the polyploidization and binucleation at the weaning stage, as discussed below [37, 60, 61].
While it has long been known that ploidy of hepatocytes increases after PHx [14, 36, 37, 62], its mechanism remains unknown. Although a majority of hepatocytes undergo S phase in regenerating liver after 70% PHx, not all hepatocytes undergo cell division, resulting in an increase in ploidy. We noticed that the ratio of hepatocytes that were positive for phosphorylated histone H3 (an M phase marker) to those that were positive for Ki67 (a G1 to M phase marker) in liver regeneration is much lower than that in postnatal liver, where hepatocytes actively undergo cell division . These results suggest that M phase progression is compromised in liver regeneration.
M phase promoting factor (MPF), composed of cyclin B and Cdk1, regulates entry into M phase [63, 64], and MPF must be activated for cell transition from G2 to M phase. Cdk1 is phosphorylated at three amino acid residues (Thr-14, Tyr-15, and Thr-161) in the inactive form of MPF, whereas Cdk1 dephosphorylation at Thr-14 and Tyr-15 by cell division cycle 25 (Cdc25) activates MPF . We found that the phosphorylation level of Cdk1 at Tyr-15 was much higher in regenerating liver compared to postnatal liver. Therefore, the lower activity of MPF in regenerating liver could be a cause of the infrequent entry into M phase. In fact, MPF activity is dispensable for liver regeneration; hepatocytes increase their size to regenerate liver after 70% PHx without cell division, even in the absence of Cdk1 .
In contrast to the G2 to M phase transition, the G1 to S phase transition is driven mainly by cyclin D/A2 and Cdk2 in normal cell division and endoreplication . Therefore, it is intriguing to compare the activity of Cdk2 in liver regeneration with that in liver development. As hepatocytes increase their ploidy in both postnatal liver development and regeneration, the cell cycle regulators driving the G1 to S phase transition seem to dominate those driving the G2 to M phase transition in mature hepatocytes. Although the exact molecular mechanism that blocks the entry of hepatocytes into M phase in regenerating liver remains elusive, a crucial role of the E2F family transcription factors has been reported recently [67, 68]. The E2F family consists of E2F transcription activators and transcription repressors and regulates cell cycle progression. Using mouse genetic models, these studies clearly showed that atypical E2F repressors E2F7 and E2F8 inhibit the completion of cell division to enhance polyploidy and binucleation in hepatocytes both in liver development and regeneration, whereas the canonical activator E2F1 counteracts their activities. These E2Fs differentially control the transcription of cell cycle regulators to either enhance or inhibit the G2 to M phase transition.
Cell division of binuclear hepatocytes to produce mononuclear cells
Binucleation is another interesting feature in adult hepatocytes that begins from the neonatal liver . It has long been known that the number of binuclear hepatocytes decreases during liver regeneration after 70% PHx, as assessed by microscopic observations and manual counting [13–15, 69–71]. Weaning increases the amount of circulating insulin to activate Akt signaling, which induces incomplete cytokinesis to generate binuclear hepatocytes during liver maturation [37, 60, 61]. In contrast, even though Akt is activated by PHx, the number of binuclear hepatocytes decreases in regenerating liver, suggesting that Akt has different functions in liver maturation and regeneration. Indeed, Akt signaling induces hypertrophy of hepatocytes in liver regeneration (our unpublished data). The different responses to Akt may be due to the molecular targets of the Akt signaling pathway differing according to the cellular context. mTOR is a major downstream molecule of Akt that functions in induction of hypertrophy. Because the E2F family transcription factors regulate the progression of M phase [67, 68], it is tempting to speculate a link between Akt signaling and E2Fs in binucleation. Indeed, it is already known that this link exits in other cell types [72, 73].
Binucleation is generally considered a sign of terminal differentiation in both hepatocytes and cardiomyocytes [77, 78]; however, in contrast to binuclear hepatocytes, binuclear cardiomyocytes do not divide. Mononuclear and binuclear cardiomyocytes seem to have distinct functions, and it has been proposed that only mononuclear cardiomyocytes maintain their proliferative potential to serve as stem or progenitor cells in heart muscle [79, 80]. It is unclear whether hepatocytes with different numbers of nuclei have different functions. This issue is discussed further below.
A revised model of liver regeneration
Cellular properties of hepatocytes in regenerated liver after 30 and 70% PHx, compared to normal liver
Cellular robustness of hepatocytes
Adult hepatocytes can be binuclear, polyploid and even aneuploid under normal conditions [76, 81]. Furthermore, cell number, cell size, nuclear number and ploidy of hepatocytes are significantly different in normal liver and regenerated liver after 30% or 70% PHx (Table 1). Despite these differences, liver seems to function almost equally in different conditions, which raises an intriguing question whether such differences in the cellular properties affect hepatocytes. One study using transcriptomic analysis showed that hepatocytes with different ploidy were basically indistinguishable ; however, another study indicated that polyploid cells were more resistant to stressful conditions . Hepatocytes with different ploidy were shown to be equally susceptible to interferon-γ (IFN-γ)-induced apoptosis . Proliferation of polyploid hepatocytes was compromised and they exhibited more characteristics of senescence . No consensus has been reached on the functional differences in hepatocytes of different ploidy or number of nuclei. The volume of hepatocytes is basically proportional to their ploidy, which is often the case with other cell types [42, 84, 86, 87]. However, we noticed that hepatocytes increase their size without increasing their DNA content after 30% PHx , suggesting that hypertrophy without increased ploidy allows hepatocytes to function properly. Naturally occurring aneuploidy is another feature of hepatocytes, which seems to arise from inaccurate chromosome segregation [76, 81]. Aneuploidy is often associated with genetic disorders and is observed in various cancers [88, 89]. However, aneuploidy does not seem to be tumorigenic in hepatocytes, and it may even provide genetic diversity in hepatocytes to perform different functions .
In addition to these characteristic features exhibited by wild-type mice, genetically modified mice show rather extreme phenotypes of hepatocytes. Mutant mice with impaired cell cycle progression showed a fully functional liver with extraordinarily enlarged hepatocytes after 70% PHx [44–47]. A loss of E2F7 and E2F8 reduced ploidy or nuclear number but did not affect hepatocyte function and regeneration after several liver injuries including PHx [67, 68]. Furthermore, hepatocytes were resistant to DNA damage caused by a lack of telomeric repeat binding factor 2 (TRF2). In the absence of TRF2, liver regenerated by increasing the size and ploidy of hepatocytes and was fully functional after 70% PHx . These observations indicate collectively that hepatocytes have a “cellular robustness” which allows them to perform their functions in a variety of settings; these differ in terms of cell size, ploidy or nuclear number. The observed extreme plasticity in ploidy of hepatocytes supports their robustness . It is tempting to speculate that the cellular robustness of hepatocytes is one reason why of mammalian organs, only the liver has such a marked regenerative capacity.
Size control of organs
Liver regeneration serves as an excellent model for regulation of organ size. Generally, differences in organ size among animals reflect differences in cell number rather than cell size [91, 92]. Limb regeneration in amphibians also depends on an increase in cell number to fully recover the original tissues. However, the size and number of hepatocytes in liver regeneration after PHx contribute differentially to the recovery of liver mass. It has been suggested that removal of one kidney induces the enlargement of the other by increasing the size of kidney cells . Moreover, physiological and pathological cardiac hyperplasia is induced by hypertrophy of cardiomyocytes [94, 95]. Therefore, cellular hypertrophy could be a general mechanism for increasing organ size. Hippo/mammalian Ste-20 like kinase (Mst)1/2-Yorkie/Yes-associated protein (YAP) signaling plays an indispensable role in the regulation of organ size [96–99]. In normal adult hepatocytes, Mst1/2 kinase (the mammalian homologue of Drosophila Hippo) phosphorylates and inactivates YAP (the mammalian homologue of Drosophila Yorkie), which is a transcription activator that induces cell proliferation and suppresses apoptosis. Transgenic expression of human YAP in mouse hepatocytes drastically increased the liver size . This regulation of organ size by Hippo/Mst1/2-Yorkie/YAP signaling might be due mainly to the control of proliferation and apoptosis in cells . However, Hippo/Mst1/2-Yorkie/YAP signaling affects cell size by tuning Akt-mTOR signaling via miRNA , demonstrating that cell size plays a critical role in organ size regulation by Hippo/Mst1/2-Yorkie/YAP signaling as well.
What senses and regulates liver size is a fundamental question. The decreased number of hepatocytes and increased size of hepatocytes in regenerated liver suggests that liver size is determined by the total mass of hepatocytes. PHx drastically changes the blood flow into the liver. This increased blood flow generates shear stress that induces nitric oxide production, triggering regeneration [102–106]. In addition, the amount of bile acid in the blood might serve as a mechanism of monitoring the size of liver because it reflects the total mass of the hepatocytes [107, 108]. Additionally, because the liver serves as a major reservoir of glycogen, the blood glucose level reflects the liver mass and so might also be a sensor. Consistent with this hypothesis, it has long been known that rodents become hypoglycemic after PHx, and supplementation of glucose inhibits liver regeneration [109–111]. This inhibitory effect of glucose is suggested to be mediated by p21 . Other factors in the regulation of liver size might be cytokines and serum proteins secreted from hepatocytes. A key contributing feature of these factors is that they must reflect the total mass of hepatocytes, but not the number or size of individual hepatocytes. Although these factors may sense the liver size, the mechanism of initiating and promoting regenerative responses remains unknown. Furthermore, liver regeneration must terminate when the liver recovers its original mass. Several molecules have been suggested to be involved in the termination of liver regeneration including transforming growth factor-β (TGF-β), a mitoinhibitory cytokine for hepatocytes ; extracellular matrix, which might inhibit proliferation of hepatocytes via integrin-linked kinase (ILK) and glypican 3 [114–116]; and peroxisome proliferator-activated receptor-γ (PPAR-γ) a mitoinhibitory transcription factor for hepatocytes . However, the termination of liver regeneration has been inadequately studied compared to the initiation process. Recent transcriptome analyses of termination may shed light on its underlying molecular mechanisms [118, 119]. A future challenge is to elucidate the molecular links between the sensors of liver size, the factors that regulate the hypertrophic and proliferative responses of hepatocytes, and the termination process of liver regeneration that acts to maintain the appropriate liver size.
Although liver regeneration has been studied extensively, many important fundamental mechanisms remain undefined such as the mechanisms of cellular hypertrophy, cell division, nuclear division, ploidy changes and organ size control. Liver regeneration after PHx provides an excellent experimental system to tackle such basic biological questions. Understanding the mechanisms underlying liver regeneration is clinically important because hepatectomy is a practical treatment for liver tumors, and liver transplantation is an important therapeutic option in patients with severe liver diseases. Understanding the mechanism of liver regeneration will lead to the development of promising therapeutic strategies.
We thank Dr. T. Itoh for his critical reading of this manuscript. YM is a recipient of a JSPS Postdoctoral Fellowship for Research Abroad and an Uehara Memorial Foundation Research Fellowship. This work was supported in part by research grants to AM from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Ministry of Health, Labour and Welfare of Japan, and the CREST program from Japan Science and Technology Agency.
- Palmes D, Spiegel HU: Animal models of liver regeneration. Biomaterials 2004, 25: 1601–1611. 10.1016/S0142-9612(03)00508-8PubMed
- Alison MR, Islam S, Lim S: Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009, 217: 282–298. 10.1002/path.2453PubMed
- Si-Tayeb K, Lemaigre FP, Duncan SA: Organogenesis and development of the liver. Dev Cell 2010, 18: 175–189. 10.1016/j.devcel.2010.01.011PubMed
- Zaret KS, Grompe M: Generation and regeneration of cells of the liver and pancreas. Science 2008, 322: 1490–1494. 10.1126/science.1161431PubMed CentralPubMed
- Tanaka M, Itoh T, Tanimizu N, Miyajima A: Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J Biochem 2011, 149: 231–239. 10.1093/jb/mvr001PubMed
- Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ: The mystery of liver regeneration. Br J Surg 2002, 89: 1089–1095. 10.1046/j.1365-2168.2002.02166.xPubMed
- Fausto N: Liver regeneration. J Hepatol 2000, 32: 19–31.PubMed
- Michalopoulos GK: Liver regeneration. J Cell Physiol 2007, 213: 286–300. 10.1002/jcp.21172PubMed CentralPubMed
- Michalopoulos GK, DeFrances M: Liver regeneration. Adv Biochem Eng Biotechnol 2005, 93: 101–134.PubMed
- Brockes JP, Kumar A: Comparative aspects of animal regeneration. Annu Rev Cell Dev Biol 2008, 24: 525–549. 10.1146/annurev.cellbio.24.110707.175336PubMed
- Milne LS: The histology of liver tissue regeneration. J Pathol Bacteriol 1909, 13: 127–160. 10.1002/path.1700130121
- Higgins G, Anderson GM: Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931, 12: 186–202.
- Beams HW, King RL: The origin of binucleate and large mono nucleate cells in the liver of the rat. Anat Rec 1942, 83: 281–297. 10.1002/ar.1090830207
- Sulkin NM: A study of the nucleus in the normal and hyperplastic liver of the rat. Am J Anat 1943, 73: 107–125.
- St Aubin PM, Bucher NL: A study of binucleate cell counts in resting and regenerating rat liver employing a mechanical method for the separation of liver cells. Anat Rec 1952, 112: 797–809. 10.1002/ar.1091120406PubMed
- Jordan SW: Electron Microscopy of Hepatic Regeneration. Exp Mol Pathol 1964, 86: 183–200.PubMed
- Stenger RJ, Confer DB: Hepatocellular ultrastructure during liver regeneration after subtotal hepatectomy. Exp Mol Pathol 1966, 5: 455–474. 10.1016/0014-4800(66)90026-8PubMed
- Aterman K: Electron microscopy of the rat liver cell after partial hepatectomy. J Pathol Bacteriol 1961, 82: 367–369. 10.1002/path.1700820215PubMed
- Fisher ER, Fisher B: Ultrastructural Hepatic Changes Following Partial Hepatectomy and Portacaval Shunt in the Rat. Lab Invest 1963, 12: 929–942.PubMed
- Grisham JW: A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res 1962, 22: 842–849.PubMed
- Bucher NL, Swaffield MN: The Rate of Incorporation of Labeled Thymidine into the Deoxyribonucleic Acid of Regenerating Rat Liver in Relation to the Amount of Liver Excised. Cancer Res 1964, 24: 1611–1625.PubMed
- Fabrikant JI: The kinetics of cellular proliferation in regenerating liver. J Cell Biol 1968, 36: 551–565. 10.1083/jcb.36.3.551PubMed CentralPubMed
- Bucher NL, Swaffield MN: Rate of incorporation of [6–14C]orotic acid into uridine 5′-triphosphate and cytidine 5′-triphosphate and nuclear ribonucleic acid in regenerating rat liver. Biochim Biophys Acta 1965, 108: 551–567. 10.1016/0005-2787(65)90052-3PubMed
- Bucher NL, Oakman NJ: Thymidine triphosphate content of regenerating rat liver. Biochim Biophys Acta 1969, 186: 13–20. 10.1016/0005-2787(69)90485-7PubMed
- Stocker E, Pfeifer U: [On the manner of proliferation of the liver parenchyma after partial hepatectomy. Autoradiography studies using 3H-thymidine]. Naturwissenschaften 1965, 52: 663.PubMed
- Fausto N, Campbell JS, Riehle KJ: Liver regeneration. Hepatology 2006, 43: S45-S53. 10.1002/hep.20969PubMed
- Duncan AW, Dorrell C, Grompe M: Stem cells and liver regeneration. Gastroenterology 2009, 137: 466–481. 10.1053/j.gastro.2009.05.044PubMed CentralPubMed
- Koller BH, Hagemann LJ, Doetschman T, Hagaman JR, Huang S, Williams PJ, First NL, Maeda N, Smithies O: Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 1989, 86: 8927–8931. 10.1073/pnas.86.22.8927PubMed CentralPubMed
- Schwartzberg PL, Goff SP, Robertson EJ: Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 1989, 246: 799–803. 10.1126/science.2554496PubMed
- Thompson S, Clarke AR, Pow AM, Hooper ML, Melton DW: Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 1989, 56: 313–321. 10.1016/0092-8674(89)90905-7PubMed
- Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP: Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006, 131: 1561–1572. 10.1053/j.gastro.2006.08.042PubMed
- Chen L, Zeng Y, Yang H, Lee TD, French SW, Corrales FJ, Garcia-Trevijano ER, Avila MA, Mato JM, Lu SC: Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J 2004, 18: 914–916.PubMed
- Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A: Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 2004, 39: 635–644. 10.1002/hep.20086PubMed
- Beyer TA, Xu W, Teupser D, Auf Dem Keller U, Bugnon P, Hildt E, Thiery J, Kan YW, Werner S: Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J 2008, 27: 212–223. 10.1038/sj.emboj.7601950PubMed CentralPubMed
- Factor VM, Seo D, Ishikawa T, Kaposi-Novak P, Marquardt JU, Andersen JB, Conner EA, Thorgeirsson SS: Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice. PLoS One 2010, 5: e12739. 10.1371/journal.pone.0012739PubMed CentralPubMed
- Geschwind II, Alfert M, Schooley C: Liver regeneration and hepatic polyploidy in the hypophysectomized rat. Exp Cell Res 1958, 15: 232–235. 10.1016/0014-4827(58)90080-6PubMed
- Gentric G, Celton-Morizur S, Desdouets C: Polyploidy and liver proliferation. Clin Res Hepatol Gastroenterol 2012, 36: 29–34. 10.1016/j.clinre.2011.05.011PubMed
- Miyaoka Y, Ebato K, Kato H, Arakawa S, Shimizu S, Miyajima A: Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol 2012, 22: 1166–1175. 10.1016/j.cub.2012.05.016PubMed
- Herweijer H, Wolff JA: Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther 2007, 14: 99–107.PubMed
- Wooddell CI, Reppen T, Wolff JA, Herweijer H: Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery. J Gene Med 2008, 10: 551–563.PubMed
- Mitchell C, Nivison M, Jackson LF, Fox R, Lee DC, Campbell JS, Fausto N: Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration. J Biol Chem 2005, 280: 2562–2568.PubMed
- Conlon I, Raff M: Size control in animal development. Cell 1999, 96: 235–244. 10.1016/S0092-8674(00)80563-2PubMed
- Su AI, Guidotti LG, Pezacki JP, Chisari FV, Schultz PG: Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice. Proc Natl Acad Sci USA 2002, 99: 11181–11186. 10.1073/pnas.122359899PubMed CentralPubMed
- Haga S, Ogawa W, Inoue H, Terui K, Ogino T, Igarashi R, Takeda K, Akira S, Enosawa S, Furukawa H, et al.: Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J Hepatol 2005, 43: 799–807. 10.1016/j.jhep.2005.03.027PubMed
- Minamishima YA, Nakayama K: Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice. Cancer Res 2002, 62: 995–999.PubMed
- Wirth KG, Wutz G, Kudo NR, Desdouets C, Zetterberg A, Taghybeeglu S, Seznec J, Ducos GM, Ricci R, Firnberg N, et al.: Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. J Cell Biol 2006, 172: 847–860. 10.1083/jcb.200506119PubMed CentralPubMed
- Diril MK, Ratnacaram CK, Padmakumar VC, Du T, Wasser M, Coppola V, Tessarollo L, Kaldis P: Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration. Proc Natl Acad Sci USA 2012, 109: 3826–3831. 10.1073/pnas.1115201109PubMed CentralPubMed
- Nagy P, Teramoto T, Factor VM, Sanchez A, Schnur J, Paku S, Thorgeirsson SS: Reconstitution of liver mass via cellular hypertrophy in the rat. Hepatology 2001, 33: 339–345. 10.1053/jhep.2001.21326PubMed
- Trotter NL: A Fine Structure Study of Lipid in Mouse Liver Regenerating after Partial Hepatectomy. J Cell Biol 1964, 21: 233–244. 10.1083/jcb.21.2.233PubMed CentralPubMed
- Trotter NL: Electron-opaque, lipid-containing bodies in mouse liver at early intervals after partial hepatectomy and sham operation. J Cell Biol 1965,25(Suppl):41–52.PubMed CentralPubMed
- Shteyer E, Liao Y, Muglia LJ, Hruz PW, Rudnick DA: Disruption of hepatic adipogenesis is associated with impaired liver regeneration in mice. Hepatology 2004, 40: 1322–1332. 10.1002/hep.20462PubMed
- Murray AB, Strecker W, Silz S: Ultrastructural changes in rat hepatocytes after partial hepatectomy, and comparison with biochemical results. J Cell Sci 1981, 50: 433–448.PubMed
- Kozma SC, Thomas G: Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays 2002, 24: 65–71. 10.1002/bies.10031PubMed
- Kim S, Li Q, Dang CV, Lee LA: Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Natl Acad Sci USA 2000, 97: 11198–11202. 10.1073/pnas.200372597PubMed CentralPubMed
- Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, et al.: Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol 2004, 2: e332. 10.1371/journal.pbio.0020332PubMed CentralPubMed
- Baena E, Gandarillas A, Vallespinos M, Zanet J, Bachs O, Redondo C, Fabregat I, Martinez AC, De Alboran IM: c-Myc regulates cell size and ploidy but is not essential for postnatal proliferation in liver. Proc Natl Acad Sci USA 2005, 102: 7286–7291. 10.1073/pnas.0409260102PubMed CentralPubMed
- Ruvinsky I, Meyuhas O: Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006, 31: 342–348. 10.1016/j.tibs.2006.04.003PubMed
- Jorgensen P, Tyers M: How cells coordinate growth and division. Curr Biol 2004, 14: R1014-R1027. 10.1016/j.cub.2004.11.027PubMed
- Gentric G, Desdouets C, Celton-Morizur S: Hepatocytes polyploidization and cell cycle control in liver physiopathology. Int J Hepatol 2012, 2012: 282430.PubMed CentralPubMed
- Celton-Morizur S, Merlen G, Couton D, Desdouets C: Polyploidy and liver proliferation: central role of insulin signaling. Cell Cycle 2010, 9: 460–466. 10.4161/cc.9.3.10542PubMed
- Celton-Morizur S, Merlen G, Couton D, Margall-Ducos G, Desdouets C: The insulin/Akt pathway controls a specific cell division program that leads to generation of binucleated tetraploid liver cells in rodents. J Clin Invest 2009, 119: 1880–1887.PubMed CentralPubMed
- Satyanarayana A, Wiemann SU, Buer J, Lauber J, Dittmar KEJ, Wustefeld T, Blasco MA, Manns MP, Rudolph KL: Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J 2003, 22: 4003–4013. 10.1093/emboj/cdg367PubMed CentralPubMed
- Enserink JM, Kolodner RD: An overview of Cdk1-controlled targets and processes. Cell Div 2010, 5: 11. 10.1186/1747-1028-5-11PubMed CentralPubMed
- Bloom J, Cross FR: Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol 2007, 8: 149–160. 10.1038/nrm2105PubMed
- Norbury C, Blow J, Nurse P: Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J 1991, 10: 3321–3329.PubMed CentralPubMed
- Lee HO, Davidson JM, Duronio RJ: Endoreplication: polyploidy with purpose. Genes Dev 2009, 23: 2461–2477. 10.1101/gad.1829209PubMed CentralPubMed
- Chen HZ, Ouseph MM, Li J, Pecot T, Chokshi V, Kent L, Bae S, Byrne M, Duran C, Comstock G, et al.: Canonical and atypical E2Fs regulate the mammalian endocycle. Nat Cell Biol 2012, 14: 1192–1202. 10.1038/ncb2595PubMed CentralPubMed
- Pandit SK, Westendorp B, Nantasanti S, Van Liere E, Tooten PC, Cornelissen PW, Toussaint MJ, Lamers WH, de Bruin A: E2F8 is essential for polyploidization in mammalian cells. Nat Cell Biol 2012, 14: 1181–1191. 10.1038/ncb2585PubMed
- Harrison MF: Percentage of binucleate cells in the livers of adult rats. Nature 1953, 171: 611. 10.1038/171611a0PubMed
- Wheatley DN: Binucleation in mammalian liver. Studies on the control of cytokinesis in vivo. Exp Cell Res 1972, 74: 455–465. 10.1016/0014-4827(72)90401-6PubMed
- Gerlyng P, Abyholm A, Grotmol T, Erikstein B, Huitfeldt HS, Stokke T, Seglen PO: Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Prolif 1993, 26: 557–565. 10.1111/j.1365-2184.1993.tb00033.xPubMed
- Yu JT, Foster RG, Dean DC: Transcriptional repression by RB-E2F and regulation of anchorage-independent survival. Mol Cell Biol 2001, 21: 3325–3335. 10.1128/MCB.21.10.3325-3335.2001PubMed CentralPubMed
- Brennan P, Babbage JW, Burgering BM, Groner B, Reif K, Cantrell DA: Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 1997, 7: 679–689. 10.1016/S1074-7613(00)80388-XPubMed
- Ruchaud S, Carmena M, Earnshaw WC: Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 2007, 8: 798–812. 10.1038/nrm2257PubMed
- Guidotti JE, Bregerie O, Robert A, Debey P, Brechot C, Desdouets C: Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem 2003, 278: 19095–19101. 10.1074/jbc.M300982200PubMed
- Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB, Finegold MJ, Grompe M: The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010, 467: 707–710. 10.1038/nature09414PubMed CentralPubMed
- Thornburg K, Jonker S, O'Tierney P, Chattergoon N, Louey S, Faber J, Giraud G: Regulation of the cardiomyocyte population in the developing heart. Prog Biophys Mol Biol 2011, 106: 289–299. 10.1016/j.pbiomolbio.2010.11.010PubMed CentralPubMed
- Liu Z, Yue S, Chen X, Kubin T, Braun T: Regulation of cardiomyocyte polyploidy and multinucleation by CyclinG1. Circ Res 2010, 106: 1498–1506. 10.1161/CIRCRESAHA.109.211888PubMed
- Sedmera D, Thompson RP: Myocyte proliferation in the developing heart. Dev Dyn 2011, 240: 1322–1334. 10.1002/dvdy.22650PubMed CentralPubMed
- Bersell K, Arab S, Haring B, Kuhn B: Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138: 257–270. 10.1016/j.cell.2009.04.060PubMed
- Duncan AW, Hanlon Newell AE, Smith L, Wilson EM, Olson SB, Thayer MJ, Strom SC, Grompe M: Frequent aneuploidy among normal human hepatocytes. Gastroenterology 2012, 142: 25–28. 10.1053/j.gastro.2011.10.029PubMed CentralPubMed
- Lu P, Prost S, Caldwell H, Tugwood JD, Betton GR, Harrison DJ: Microarray analysis of gene expression of mouse hepatocytes of different ploidy. Mamm Genome 2007, 18: 617–626. 10.1007/s00335-007-9048-yPubMed
- Anatskaya OV, Vinogradov AE: Genome multiplication as adaptation to tissue survival: evidence from gene expression in mammalian heart and liver. Genomics 2007, 89: 70–80. 10.1016/j.ygeno.2006.08.014PubMed
- Martin NC, McCullough CT, Bush PG, Sharp L, Hall AC, Harrison DJ: Functional analysis of mouse hepatocytes differing in DNA content: volume, receptor expression, and effect of IFNgamma. J Cell Physiol 2002, 191: 138–144. 10.1002/jcp.10057PubMed
- Sigal SH, Rajvanshi P, Gorla GR, Sokhi RP, Saxena R, Gebhard DR Jr, Reid LM, Gupta S: Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol 1999, 276: G1260-G1272.PubMed
- Fankhauser G: Maintenance of normal structure in heteroploid salamander larvae, through compensation of changes in cell size by adjustment of cell number and cell shape. J Exp Zool 1945, 100: 445–455. 10.1002/jez.1401000310PubMed
- Henery CC, Bard JB, Kaufman MH: Tetraploidy in mice, embryonic cell number, and the grain of the developmental map. Dev Biol 1992, 152: 233–241. 10.1016/0012-1606(92)90131-YPubMed
- Holland AJ, Cleveland DW: Losing balance: the origin and impact of aneuploidy in cancer. EMBO Rep 2012, 13: 501–514. 10.1038/embor.2012.55PubMed CentralPubMed
- Pfau SJ, Amon A: Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep 2012, 13: 515–527. 10.1038/embor.2012.65PubMed CentralPubMed
- Lazzerini Denchi E, Celli G, de Lange T: Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Genes Dev 2006, 20: 2648–2653. 10.1101/gad.1453606PubMed CentralPubMed
- Raff MC: Size control: the regulation of cell numbers in animal development. Cell 1996, 86: 173–175. 10.1016/S0092-8674(00)80087-2PubMed
- Savage VM, Allen AP, Brown JH, Gillooly JF, Herman AB, Woodruff WH, West GB: Scaling of number, size, and metabolic rate of cells with body size in mammals. Proc Natl Acad Sci USA 2007, 104: 4718–4723. 10.1073/pnas.0611235104PubMed CentralPubMed
- Liu B, Preisig PA: Compensatory renal hypertrophy is mediated by a cell cycle-dependent mechanism. Kidney Int 2002, 62: 1650–1658. 10.1046/j.1523-1755.2002.00620.xPubMed
- Harvey PA, Leinwand LA: The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol 2011, 194: 355–365. 10.1083/jcb.201101100PubMed CentralPubMed
- Watkins H, Ashrafian H, Redwood C: Inherited cardiomyopathies. N Engl J Med 2011, 364: 1643–1656. 10.1056/NEJMra0902923PubMed
- Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D: Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130: 1120–1133. 10.1016/j.cell.2007.07.019PubMed CentralPubMed
- Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM, et al.: Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 2010, 107: 1431–1436. 10.1073/pnas.0911409107PubMed CentralPubMed
- Tumaneng K, Russell RC, Guan KL: Organ size control by Hippo and TOR pathways. Curr Biol 2012, 22: R368-R379. 10.1016/j.cub.2012.03.003PubMed CentralPubMed
- Pan D: Hippo signaling in organ size control. Genes Dev 2007, 21: 886–897. 10.1101/gad.1536007PubMed
- Tordjmann T: Hippo signalling: liver size regulation and beyond. Clin Res Hepatol Gastroenterol 2011, 35: 344–346. 10.1016/j.clinre.2011.01.012PubMed
- Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, Fitamant J, Bardeesy N, Camargo FD, Guan KL: YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 2012, 14: 1322–1329. 10.1038/ncb2615PubMed CentralPubMed
- Wang HH, Lautt WW: Evidence of nitric oxide, a flow-dependent factor, being a trigger of liver regeneration in rats. Can J Physiol Pharmacol 1998, 76: 1072–1079. 10.1139/y98-128PubMed
- Schoen JM, Wang HH, Minuk GY, Lautt WW: Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 2001, 5: 453–464. 10.1006/niox.2001.0373PubMed
- Macedo MP, Lautt WW: Shear-induced modulation of vasoconstriction in the hepatic artery and portal vein by nitric oxide. Am J Physiol 1998, 274: G253-G260.PubMed
- Sato Y, Tsukada K, Hatakeyama K: Role of shear stress and immune responses in liver regeneration after a partial hepatectomy. Surg Today 1999, 29: 1–9. 10.1007/BF02482962PubMed
- Niiya T, Murakami M, Aoki T, Murai N, Shimizu Y, Kusano M: Immediate increase of portal pressure, reflecting sinusoidal shear stress, induced liver regeneration after partial hepatectomy. J Hepatobiliary Pancreat Surg 1999, 6: 275–280. 10.1007/s005340050118PubMed
- Huang W, Ma K, Zhang J, Qatanani M, Cuvillier J, Liu J, Dong B, Huang X, Moore DD: Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 2006, 312: 233–236. 10.1126/science.1121435PubMed
- Meng Z, Liu N, Fu X, Wang X, Wang YD, Chen WD, Zhang L, Forman BM, Huang W: Insufficient bile acid signaling impairs liver repair in CYP27(−/−) mice. J Hepatol 2011, 55: 885–895. 10.1016/j.jhep.2010.12.037PubMed
- Holecek M: Nutritional modulation of liver regeneration by carbohydrates, lipids, and amino acids: a review. Nutrition 1999, 15: 784–788. 10.1016/S0899-9007(99)00158-6PubMed
- Simek J, Chmelar V, Melka J, Pazderka , Charvat Z: Influence of protracted infusion of glucose and insulin on the composition and regeneration activity of liver after partial hepatectomy in rats. Nature 1967, 213: 910–911. 10.1038/213910a0PubMed
- Simek J, Melka J, Pospisil M, Neradilkova M: Effect of protracted glucose infusion on the development of early biochemical changes and initiation of regeneration in rat liver after partial hepatectomy. Physiol Bohemoslov 1965, 14: 366–370.PubMed
- Weymann A, Hartman E, Gazit V, Wang C, Glauber M, Turmelle Y, Rudnick DA: p21 is required for dextrose-mediated inhibition of mouse liver regeneration. Hepatology 2009, 50: 207–215. 10.1002/hep.22979PubMed CentralPubMed
- Carr BI, Hayashi I, Branum EL, Moses HL: Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res 1986, 46: 2330–2334.PubMed
- Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S, Orr A, Monga SP, Wu C, Michalopoulos GK: Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 2009, 50: 844–851. 10.1002/hep.23059PubMed CentralPubMed
- Liu B, Bell AW, Paranjpe S, Bowen WC, Khillan JS, Luo JH, Mars WM, Michalopoulos GK: Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice. Hepatology 2010, 52: 1060–1067. 10.1002/hep.23794PubMed CentralPubMed
- Liu B, Paranjpe S, Bowen WC, Bell AW, Luo JH, Yu YP, Mars WM, Michalopoulos GK: Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am J Pathol 2009, 175: 717–724. 10.2353/ajpath.2009.081129PubMed CentralPubMed
- Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N: Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats. J Gastroenterol Hepatol 2008, 23: 930–937. 10.1111/j.1440-1746.2008.05370.xPubMed
- Nygard IE, Mortensen KE, Hedegaard J, Conley LN, Kalstad T, Bendixen C, Revhaug A: The genetic regulation of the terminating phase of liver regeneration. Comp Hepatol 2012, 11: 3. 10.1186/1476-5926-11-3PubMed CentralPubMed
- Rychtrmoc D, Hubalkova L, Viskova A, Libra A, Buncek M, Cervinkova Z: Transcriptome temporal and functional analysis of liver regeneration termination. Physiol Res 2012,61(Suppl 2):S77-S92.PubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.